Table II.
Clinical features of patients with retroperitoneal and non-retroperitoneal liposarcomas.
| Patient | Sex | Age, years | Location | Clinical presentation | Group | Diagnosis | Size, cm | Histology |
|---|---|---|---|---|---|---|---|---|
| Patient 1 | Female | 45 | Retroperitoneal | Tumour | Group A | CT | 22×16 | WDL/ALT |
| Patient 2 | Male | 69 | Upper limb | Tumour | Group B | US | 7×6×3 | WDL/ALT |
| Patient 3 | Male | 33 | Upper limb | Tumour | Group B | CT + US | 7×8 | MLP |
| Patient 4 | Male | 53 | Upper limb | Tumour | Group B | CT | 6 | PLP |
| Patient 5 | Female | 47 | Upper limb | Local pain | Group B | MRI | 9X6 | WDL/ALT |
| Patient 6 | Male | 63 | Lower limb | Tumour | Group B | US | 10×8×5 | WDL/ALT |
| Patient 7 | Female | 47 | Back | Tumour | Group B | US | 7.5×3.2×3.7 | WDL/ALT |
| Patient 8 | Male | 49 | Back | Tumour | Group B | US | 14×6.5×2 | WDL/ALT |
| Patient 9 | Female | 54 | Lower limb | Tumour | Group B | US | 3×3×1.5 | WDL/ALT |
| Patient 10 | Male | 43 | Lower limb | Tumour | Group B | US | 6×4×3.5 | WDL/ALT |
| Patient 11 | Female | 41 | Upper limb | Tumour | Group B | US | 7×3.5×3 | WDL/ALT |
| Patient 12 | Male | 82 | Lower limb | Tumour | Group B | US | 10 | WDL/ALT |
| Patient 13 | Male | 69 | Lower limb | Tumour | Group B | CT+MRI | 11×9×8 | MLP |
| Patient 14 | Male | 81 | Lower limb | Tumour | Group B | CT | 15×10×8 | WDL/ALT |
| Patient 15 | Female | 57 | Retroperitoneal | Tumour | Group A | CT | 15×9 | MLP |
| Patient 16 | Female | 28 | Lower limb | Tumour | Group B | US + MRI | 20×10×15 | WDL/ALT |
| Patient 17 | Male | 22 | Lower limb | Tumour | Group B | MRI | 8×5×2 | MLP |
| Patient 18 | Female | 50 | Lower limb | Tumour | Group B | CT + MRI | 10×5.5 | MLP |
| Patient 19 | Female | 63 | Lower limb | Tumour | Group B | MRI | 13×6×2 | MLP |
| Patient 20 | Female | 71 | Lower limb | Tumour | Group B | MRI | 20×13×6 | WDL/ALT |
| Patient 21 | Male | 54 | Lower limb | Tumour | Group B | US + MRI | 18×10×10 | WDL/ALT |
| Patient 22 | Male | 40 | Lower limb | Tumour | Group B | US + MRI | 19×11×8 | MLP |
| Patient 23 | Female | 49 | Lower limb | Tumour | Group B | US + MRI | 12.5×8.5×7 | WDL/ALT |
| Patient 24 | Female | 65 | Lower limb | Tumour | Group B | CT | 11×6×3 | WDL/ALT |
| Patient 25 | Female | 84 | Lower limb | Tumour | Group B | MRI | 21×17×7 | MLP |
| Patient 26 | Male | 41 | Lower limb | Tumour | Group B | US | 11×5 | DDL |
| Patient 27 | Female | 61 | Lower limb | Tumour | Group B | US | 4×1.2×1 | PLP |
| Patient 28 | Female | 69 | Lower limb | Tumour | Group B | MRI | 12.4×10.3 | PLP |
| Patient 29 | Male | 58 | Lower limb | Tumour | Group B | MRI | 24×19×3 | WDL/ALT |
| Patient 30 | Female | 68 | Lower limb | Tumour | Group B | US | 7×6×4 | WDL/ALT |
| Patient 31 | Female | 58 | Lower limb | Local pain | Group B | MRI | 11×9×5 | WDL/ALT |
| Patient 32 | Female | 86 | Lower limb | Tumour | Group B | MRI | 23×12×16 | WDL/ALT |
| Patient 33 | Female | 61 | Lower limb | Tumour | Group B | MRI | 9×4 | WDL/ALT |
| Patient 34 | Male | 71 | Perianal | Tumour | Group B | MRI | 8×6×3 | WDL/ALT |
| Patient 35 | Male | 33 | Lower limb | Tumour | Group B | MRI | 8×3×1 | MLP |
| Patient 36 | Male | 58 | Cervical | Tumour | Group B | US | 3.3×2.5×2 | MLP |
| Patient 37 | Male | 62 | Cervical | Tumour | Group B | US | 5×5×3 | WDL/ALT |
| Patient 38 | Female | 72 | Retroperitoneal | Abdominal pain | Group A | CT + US | 20×13×10 | MLP |
| Patient 39 | Female | 56 | Retroperitoneal | Tumour | Group A | CT | 28×25×15 | MLP |
| Patient 40 | Female | 49 | Retroperitoneal | Tumour | Group A | CT | 24.5×16×6 | WDL/ALT |
| Patient 41 | Female | 76 | Retroperitoneal | Tumour | Group A | CT | 9×6.5×7 | MLP |
| Patient 42 | Male | 82 | Retroperitoneal | Incidental | Group A | CT | 4×2×2 | WDL/ALT |
| Patient 43 | Male | 45 | Retroperitoneal | Tumour | Group A | CT | 14×13×4 | WDL/ALT |
| Patient 44 | Male | 58 | Retroperitoneal | Abdominal pain | Group A | CT + MRI | 16×11×13 | WDL/ALT |
| Patient 45 | Male | 46 | Retroperitoneal | Tumour | Group A | CT | 33×20×15 | PLP |
| Patient 46 | Male | 80 | Retroperitoneal | Ascites | Group A | CT | 25×18×12 | DDL |
| Patient 47 | Female | 64 | Retroperitoneal | Anaemia | Group A | CT | 21×18×13 | DDL |
| Patient 48 | Male | 59 | Retroperitoneal | Tumour | Group A | CT | 8×7×7.5 | WDL/ALT |
| Patient 49 | Female | 42 | Retroperitoneal | Asthenia | Group A | CT + US | 20×12×8 | DDL |
| Patient 50 | Female | 76 | Retroperitoneal | Abdominal pain | Group A | CT + US | 12×10×3 | DDL |
| Patient 51 | Female | 63 | Retroperitoneal | Abdominal pain | Group A | CT + MRI | 18×15×12 | DDL |
| Patient 52 | Male | 76 | Testicular | Tumour | Group B | US | 3×3×2 | DDL |
CT, computed tomography; US, ultrasound; MRI, magnetic resonance imaging; WDL/ALT, well-differentiated/atypical lipomatous tumour; DDL, dedifferentiated liposarcoma; PLP, pleomorphic liposarcoma; MLP, myxoid liposarcoma.